Cet anticorps anti-CD38 (Isatuximab Biosimilar) Monoclonal Humanized (ABIN7795129) détecte spécifiquement CD38 (Isatuximab Biosimilar) dans FACS et in vivo.
L’anticorps est réactif avec des échantillons de Humain.
Aperçu rapide pour Recombinant CD38 (Isatuximab Biosimilar) anticorps (ABIN7795129)
Antigène
CD38 (Isatuximab Biosimilar)
Type d'anticorp
Recombinant Antibody
Reactivité
Humain
Hôte
Humanized
Clonalité
Monoclonal
Conjugué
Cet anticorp CD38 (Isatuximab Biosimilar) est non-conjugé
Application
Flow Cytometry (FACS), In vivo Studies (in vivo)
Classe de qualité
Research Grade
Expression System
Mammalian cells
Fonction
Isatuximab Biosimilar, CD38 Monoclonal Antibody
Attributs du produit
Isatuximab Biosimilar uses the same protein sequences as the therapeutic antibody isatuximab. Isatuximab is a humanized, IgG1-derived monoclonal antibody (mAb) produced from a Chinese hamster ovary (CHO) cell line. Structurally, isatuximab is comprised of two identical immunoglobulin kappa light chains and two identical immunoglobulin gamma heavy chains. It is a cytolytic antibody targeted against CD38, a glycoprotein found on the surface of some immune cells that is highly expressed by malignant plasma cells in multiple myeloma. Along with daratumumab, another anti-CD38 monoclonal antibody, isatuximab constitutes a novel treatment modality for patients with difficult-to-treat multiple myeloma.